Depo-Provera: an injectable contraceptive.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 8116522.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Medroxyprogesterone acetate (Depo-Provera) is now approved for use as an injectable contraceptive. It is highly effective and has the advantage of only needing to be administered once every 12 weeks. The most common side effects are menstrual irregularities, amenorrhea in particular. Several illustrative cases are presented that demonstrate appropriate patient selection for this agent.